Natalizumab and Chronic Inflammation
Clinical trial NCT05177718 · TERMINATED
Trial details
- NCT number
- NCT05177718
- Sponsor
- Vanderbilt University Medical Center
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-16
- Primary completion
- 2023-04-05
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.